Bionano Genomics, Inc. (BNGO) vs Cocrystal Pharma, Inc. (COCP)
A side-by-side comparison of Bionano Genomics, Inc. and Cocrystal Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNGO
Bionano Genomics, Inc.
$1.45HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
COCP
Cocrystal Pharma, Inc.
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BNGO vs COCP
growth of $100 · dividends reinvested · last 8yBNGO -100.0% (-62.5%/yr)COCP -97.5% (-37.0%/yr)COCP compounded faster over this window
Log scale — wide-divergence pair
BNGO COCP
BNGO vs COCP: by the numbers
- •BNGO is the larger company ($17M vs $15M market cap).
- •Both run net losses; BNGO's is the smaller (-106.58% vs -3011.52% net margin).
- •COCP grew revenue faster over the past five years (91.55% vs 17.97% CAGR).
Metrics side by side
Valuation
| Metric | BNGO | COCP |
|---|---|---|
| P/S ratio | 0.55 | 46.38 |
| P/B ratio | 0.52 | 14.66 |
Profitability
| Metric | BNGO | COCP |
|---|---|---|
| Gross margin | 21.95% | 0.00% |
| Operating margin | -116.95% | 0.00% |
| Net margin | -106.58% | -3011.52% |
| ROE | -101.76% | -951.92% |
| ROIC | -85.72% | -497.29% |
Growth (annualized)
| Metric | BNGO | COCP |
|---|---|---|
| Revenue CAGR (5Y) | 17.97% | 91.55% |
| Total return CAGR (5Y) | -78.37% | -37.50% |
Frequently asked
- Which has grown faster, BNGO or COCP?
- Over the past five years, COCP grew revenue faster — BNGO at a 17.97% CAGR versus COCP at 91.55%.
- How have BNGO and COCP total returns compared?
- Over the past 5 years, BNGO delivered -78.37% and COCP delivered -37.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bionano Genomics ROECocrystal Pharma ROEBionano Genomics operating marginCocrystal Pharma operating marginBionano Genomics revenue growthCocrystal Pharma revenue growthBionano Genomics free cash flowCocrystal Pharma free cash flow
Bionano Genomics & Cocrystal Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.